IL161902A0 - Pharmaceutical formulation comprising bicalutamide - Google Patents
Pharmaceutical formulation comprising bicalutamideInfo
- Publication number
- IL161902A0 IL161902A0 IL16190202A IL16190202A IL161902A0 IL 161902 A0 IL161902 A0 IL 161902A0 IL 16190202 A IL16190202 A IL 16190202A IL 16190202 A IL16190202 A IL 16190202A IL 161902 A0 IL161902 A0 IL 161902A0
- Authority
- IL
- Israel
- Prior art keywords
- bicalutamide
- pharmaceutical formulation
- formulation
- pharmaceutical
- Prior art date
Links
- LKJPYSCBVHEWIU-KRWDZBQOSA-N (R)-bicalutamide Chemical compound C([C@@](O)(C)C(=O)NC=1C=C(C(C#N)=CC=1)C(F)(F)F)S(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-KRWDZBQOSA-N 0.000 title 1
- 229960000997 bicalutamide Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103839A SE0103839D0 (sv) | 2001-11-16 | 2001-11-16 | Pharmaceutical formulation & product |
| PCT/GB2002/005159 WO2003043606A1 (en) | 2001-11-16 | 2002-11-14 | Pharmaceutical formulation comprising bicalutamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL161902A0 true IL161902A0 (en) | 2005-11-20 |
Family
ID=20286023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16190202A IL161902A0 (en) | 2001-11-16 | 2002-11-14 | Pharmaceutical formulation comprising bicalutamide |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20050038111A1 (de) |
| EP (1) | EP1448168B1 (de) |
| JP (1) | JP2005514355A (de) |
| KR (1) | KR20050044468A (de) |
| CN (1) | CN1615122A (de) |
| AR (1) | AR037390A1 (de) |
| AT (1) | ATE350016T1 (de) |
| AU (1) | AU2002343024A1 (de) |
| BR (1) | BR0214135A (de) |
| CA (1) | CA2466986A1 (de) |
| DE (1) | DE60217390T2 (de) |
| ES (1) | ES2278063T3 (de) |
| IL (1) | IL161902A0 (de) |
| MX (1) | MXPA04004591A (de) |
| NO (1) | NO20042502L (de) |
| SE (1) | SE0103839D0 (de) |
| TW (1) | TW200406200A (de) |
| UY (1) | UY27539A1 (de) |
| WO (1) | WO2003043606A1 (de) |
| ZA (1) | ZA200403689B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20032225A3 (cs) * | 2001-02-27 | 2003-11-12 | Astrazeneca Ab | Farmaceutická formulace |
| US7524866B2 (en) | 2001-11-29 | 2009-04-28 | Gtx, Inc. | Prevention and treatment of androgen—deprivation induced osteoporosis |
| US7332525B2 (en) * | 2003-01-17 | 2008-02-19 | Castle Erik P | Method of treatment of prostate cancer and composition for treatment thereof |
| US7226622B2 (en) | 2003-09-18 | 2007-06-05 | Boston Scientific Scimed, Inc. | Chemoablation of tissue using biodegradable, solid salt dosage forms |
| CA2554025A1 (en) * | 2004-01-28 | 2005-08-11 | Androscience Corporation | Enhancement of anti-androgenic activity by a combination of inhibitors targeting different steps of a steroid-dependent gene activation pathway and uses thereof |
| JP2008511607A (ja) * | 2004-08-31 | 2008-04-17 | ファイザー・プロダクツ・インク | 低溶解性薬物および重合体を含む医薬投与剤形 |
| GB0424339D0 (en) * | 2004-11-03 | 2004-12-08 | Astrazeneca Ab | Combination therapy |
| WO2006090129A2 (en) * | 2005-02-23 | 2006-08-31 | Astrazeneca Ab | Bicalutamide for delivering increasing steady state plasma levels |
| KR20070114343A (ko) * | 2005-03-29 | 2007-12-03 | 유에스브이 리미티드 | 비칼루타미드의 제조 방법 |
| US20090291134A1 (en) * | 2006-11-21 | 2009-11-26 | Jina Pharmaceuticals, Inc. | Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases |
| PL2252893T3 (pl) * | 2008-02-21 | 2014-03-31 | Iris Int Inc | Sposób wczesnego określenia nawrotu po leczeniu nowotworu gruczołu krokowego |
| AU2009292615B2 (en) * | 2008-09-17 | 2015-12-03 | Mylan Inc. | Granulates, process for preparing them and pharmaceutical products containing them |
| TWI673051B (zh) | 2012-09-11 | 2019-10-01 | 美商梅維森前列腺療法有限責任公司 | 恩雜魯它脈（ｅｎｚａｌｕｔａｍｉｄｅ）之調和物 |
| WO2016198983A1 (en) | 2015-06-09 | 2016-12-15 | Bend Research Inc. | Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules |
| CN107049972A (zh) * | 2017-03-17 | 2017-08-18 | 万特制药(海南)有限公司 | 一种含有来曲唑固体分散体的分散片及其制备工艺 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3121152A1 (de) * | 1981-05-22 | 1982-12-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | "verwendung der kombination eines aromatase-hemmers mit einem antiandrogen zur prophylaxe und therapie der prostatahyperplasie" |
| US4895715A (en) * | 1988-04-14 | 1990-01-23 | Schering Corporation | Method of treating gynecomastia |
| CA2181358A1 (en) * | 1994-01-21 | 1995-07-27 | Nancy M. Gray | Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex |
| GB9707800D0 (en) * | 1996-05-06 | 1997-06-04 | Zeneca Ltd | Chemical compounds |
| US6139875A (en) * | 1998-09-29 | 2000-10-31 | Eastman Chemical Company | Aqueous enteric coating composition and low gastric permeability enteric coating |
-
2001
- 2001-11-16 SE SE0103839A patent/SE0103839D0/xx unknown
-
2002
- 2002-10-31 TW TW091132270A patent/TW200406200A/zh unknown
- 2002-11-13 UY UY27539A patent/UY27539A1/es not_active Application Discontinuation
- 2002-11-14 KR KR1020047007359A patent/KR20050044468A/ko not_active Withdrawn
- 2002-11-14 JP JP2003545287A patent/JP2005514355A/ja not_active Withdrawn
- 2002-11-14 MX MXPA04004591A patent/MXPA04004591A/es unknown
- 2002-11-14 CN CNA028272277A patent/CN1615122A/zh active Pending
- 2002-11-14 AT AT02779684T patent/ATE350016T1/de not_active IP Right Cessation
- 2002-11-14 DE DE60217390T patent/DE60217390T2/de not_active Expired - Fee Related
- 2002-11-14 AU AU2002343024A patent/AU2002343024A1/en not_active Abandoned
- 2002-11-14 WO PCT/GB2002/005159 patent/WO2003043606A1/en not_active Ceased
- 2002-11-14 US US10/495,012 patent/US20050038111A1/en not_active Abandoned
- 2002-11-14 ES ES02779684T patent/ES2278063T3/es not_active Expired - Lifetime
- 2002-11-14 EP EP02779684A patent/EP1448168B1/de not_active Expired - Lifetime
- 2002-11-14 AR ARP020104386A patent/AR037390A1/es unknown
- 2002-11-14 CA CA002466986A patent/CA2466986A1/en not_active Abandoned
- 2002-11-14 BR BR0214135-3A patent/BR0214135A/pt not_active Application Discontinuation
- 2002-11-14 IL IL16190202A patent/IL161902A0/xx unknown
-
2004
- 2004-05-13 ZA ZA200403689A patent/ZA200403689B/en unknown
- 2004-06-15 NO NO20042502A patent/NO20042502L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2466986A1 (en) | 2003-05-30 |
| AR037390A1 (es) | 2004-11-10 |
| BR0214135A (pt) | 2004-10-13 |
| JP2005514355A (ja) | 2005-05-19 |
| EP1448168B1 (de) | 2007-01-03 |
| MXPA04004591A (es) | 2004-08-13 |
| US20050038111A1 (en) | 2005-02-17 |
| CN1615122A (zh) | 2005-05-11 |
| UY27539A1 (es) | 2003-07-31 |
| KR20050044468A (ko) | 2005-05-12 |
| ZA200403689B (en) | 2006-06-28 |
| SE0103839D0 (sv) | 2001-11-16 |
| DE60217390T2 (de) | 2007-11-15 |
| DE60217390D1 (de) | 2007-02-15 |
| WO2003043606A1 (en) | 2003-05-30 |
| ATE350016T1 (de) | 2007-01-15 |
| NO20042502L (no) | 2004-08-09 |
| ES2278063T3 (es) | 2007-08-01 |
| AU2002343024A1 (en) | 2003-06-10 |
| TW200406200A (en) | 2004-05-01 |
| EP1448168A1 (de) | 2004-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0302847A3 (en) | Pharmaceutical formulation comprising bicalutamide | |
| HUP0302876A3 (en) | Pharmaceutical formulation | |
| GB0319041D0 (en) | Pharmaceutical Formulations | |
| GB0118689D0 (en) | Pharmaceutical formulation | |
| GB0111597D0 (en) | Pharmaceutical compositions | |
| PL366432A1 (en) | Pharmaceutical formulation | |
| GB0121715D0 (en) | Pharmaceutical formulations | |
| GB2380129B (en) | Pharmaceutical formulations | |
| GB0103638D0 (en) | Pharmaceutical formulations | |
| GB0120701D0 (en) | Pharmaceutical formulations | |
| NO20042502L (no) | Farmasoytisk formulering omfattende bicalutamid | |
| IL161306A0 (en) | Pharmaceutical formulation comprising (r)-bicalutamide | |
| GB0105560D0 (en) | Pharmaceutical formulations | |
| GB0104752D0 (en) | Pharmaceutical compositions | |
| GB0125492D0 (en) | Formulation | |
| GB2382302B (en) | Pharmaceutical compositions | |
| ZA200306383B (en) | Pharmaceutical formulation comprising bicalutamide. | |
| GB0124455D0 (en) | Pharmaceutical formulations | |
| GB2375048B (en) | Formulation | |
| GB2396812B (en) | Formulation | |
| GB0116619D0 (en) | Formulation | |
| GB0128138D0 (en) | Pharmaceutical use | |
| HK1066729A (en) | Pharmaceutical formulation comprising bicalutamide | |
| HK1059743A (en) | Pharmaceutical formulation comprising bicalutamide | |
| GB0112497D0 (en) | Formulation |